Researchers at the University of Michigan have developed an innovative yeast-based method for producing flu vaccines, which shortens the maturation time from six months to just weeks and targets the more stable M2 protein of variable viruses, paving the way for a universal flu vaccine that could provide long-term protection against multiple virus strains. (translated)






